CIK 0001621227
- Non-accelerated filer
- Smaller reporting company
Adaptimmune Therapeutics PLC
Sign in to watch- Ticker
- ADAPY
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- Operating
- Phone
- +44 1235430000
- Business address
- 60 JUBILEE AVENUE, MILTON PARK, ABINGDON, OXFORDSHIRE, United Kingdom
- Former names
- Adaptimmune Ltd
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 1,190,476 shares at $4.20 ($4,999,999)
- 4 Open-market buy Director bought 1,190,476 shares at $4.20 ($4,999,999)
- 4 Open-market buy 10% owner bought 12,870,000 shares at $0.70 ($9,009,000)
- 4 Open-market buy 10% owner bought 12,870,000 shares at $0.70 ($9,009,000)
- 4 Open-market buy 10% owner bought 12,870,000 shares at $0.70 ($9,009,000)
- 4 Open-market buy Director bought 12,870,000 shares at $0.70 ($9,009,000)
- 4 Open-market buy 10% owner bought 12,870,000 shares at $0.70 ($9,009,000)
- 4 Open-market buy 10% owner bought 12,870,000 shares at $0.70 ($9,009,000)
- 4 Open-market buy 10% owner bought 12,870,000 shares at $0.70 ($9,009,000)
- 4 Open-market buy 10% owner bought 12,870,000 shares at $0.70 ($9,009,000)
- 4 Open-market buy 10% owner bought 12,870,000 shares at $0.70 ($9,009,000)
- 4 Open-market buy 10% owner bought 12,870,000 shares at $0.70 ($9,009,000)
Page 15 of 18 · 351 filings